Abdoul Risgou OUEDRAOGO

Dr. Abdoul Risgou OUEDRAOGO

Université Joseph KI-ZERBO, Ouagadougou, Centre, Burkina Faso
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in Atmosphere
Verified
Journal Article
Open access
PDF file
Babatunde AwokolaBabatunde Awokola
Babatunde Awokola
GOGabriel Okello
Gabriel Okello
OJOlatunji Johnson
Olatunji Johnson
RDRuaraidh Dobson
Ruaraidh Dobson
AOAbdoul Risgou OUEDRAOGO
Abdoul Risgou OUEDRAOGO
Sean SempleSean Semple
Sean Semple
Air pollution is a major global public health issue causing considerable morbidity and mortality. Measuring levels of air pollutants and facilitating access to the data has been identified as a pathway to raise awareness and initiate dialogue between relevant stakeholders. Low-and middle-income countries (LMICs) urgently need simple, low-cost approaches to generate such data, especially in settings with no or unreliable data. We established a network of easy-to-use low-cost air quality sensors (PurpleAir-II-SD) to monitor fine particulate matter (PM2.5) concentrations at 15 sites, in 11 cities across eight sub-Saharan Africa (sSA) countries between February 2020 and January 2021. Annual PM2.5 concentrations, seasonal and temporal variability were determined. Time trends were modelled using harmonic regression. Annual PM2.5 concentrations ranged between 10 and 116 µg/m3 across study sites, exceeding the current WHO annual mean guideline level of 5 µg/m3. The largest degree of seasonal variation was seen in Nigeria, where seven sites showed higher PM2.5 levels during the dry than during the wet season. Other countries with less pronounced dry/wet season variations were Benin (20 µg/m3 versus 5 µg/m3), Uganda (50 µg/m3 versus 45 µg/m3), Sukuta (Gambia) (20 µg/m3 versus 15 µg/m3) and Kenya (30 µg/m3 versus 25 µg/m3). Diurnal variation was observed across all sites, with two daily PM2.5 peaks at about 06:00 and 18:00 local time. We identified high levels of air pollution in the 11 African cities included in this study. This calls for effective control measures to protect the health of African urban populations. The PM2.5 peaks around ‘rush hour’ suggest traffic-related emissions should be a particular area for attention.

1 February 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
KPKaren Du Preez
Karen Du Preez
BGBetina Mendez Alcântara Gabardo
Betina Mendez Alcântara Gabardo
SKSushil Kumar Kabra
Sushil Kumar Kabra
RTRina Triasih
Rina Triasih
TLTrisasi Lestari
Trisasi Lestari
Steve GrahamSteve Graham
Steve Graham
Over the past 15 years, and despite many difficulties, significant progress has been made to advance child and adolescent tuberculosis (TB) care. Despite increasing availability of safe and effective treatment and prevention options, TB remains a global health priority as a major cause of child and adolescent morbidity and mortality—over one and a half million children and adolescents develop TB each year. A history of the global public health perspective on child and adolescent TB is followed by 12 narratives detailing challenges and progress in 19 TB endemic low and middle-income countries. Overarching challenges include: under-detection and under-reporting of child and adolescent TB; poor implementation and reporting of contact investigation and TB preventive treatment services; the need for health systems strengthening to deliver effective, decentralized services; and lack of integration between TB programs and child health services. The COVID-19 pandemic has had a significant negative impact on case detection and treatment outcomes. Child and adolescent TB working groups can address country-specific challenges to close the policy–practice gaps by developing and supporting decentral ized models of care, strengthening clinical and laboratory diagnosis, including of multidrug-resistant TB, providing recommended options for treatment of disease and infection, and forging strong collaborations across relevant health sectors.

17 July 2024 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
OOObianuju Ozoh
Obianuju Ozoh
NNNqobile Ndimande
Nqobile Ndimande
AAAndré F. S. Amaral
André F. S. Amaral
MLMaia Lesosky
Maia Lesosky
JMJosue Mbonigaba
Josue Mbonigaba
KMKevin Mortimer
Kevin Mortimer
Introduction Contemporary data on the burden of chronic respiratory diseases in sub-Saharan Africa is limited. More so, their economic burden is not well described. This study aims to establish a chronic respiratory disease observatory for Africa. Specific study aims are (1) to describe the prevalence and determinants of asthma with a target to screen up to 4000 children and adolescents across four African cities; (2) to determine the prevalence and determinants of chronic obstructive pulmonary disease (COPD) with a target to screen up to 3000 adults (≥18 years) across five African cities; (3) to describe the disease burden by assessing the frequency and severity of symptoms and exacerbations, medication use, emergency healthcare utilisation and hospitalisation; and (4) to assess the economic burden and affordability of the medicines for these diseases. Methods and analysis Surveys will be conducted in schools to identify children and adolescents with asthma using the Global Asthma Network screening questionnaire in Ghana, Nigeria, the Democratic Republic of Congo, and Uganda. Community surveys will be conducted among adults using an adapted version of the Burden of Obstructive Lung Disease Questionnaire to identify persons with COPD symptoms in Nigeria, Burkina Faso, Mozambique, Rwanda, and Sierra Leone. Fractional exhaled nitric oxide and pre-bronchodilator and post-bronchodilator spirometry will be done for children with asthma or asthma symptoms and for all adult participants. Children and adults with respiratory symptoms or diagnoses will complete the health economic questionnaires. Statistical analysis will involve descriptive and analytical statistics to determine outcomes. Ethics and dissemination Ethical approval has been obtained from participating institutions. This study’s results will inform deliberations at the United Nations General Assembly high-level meeting on non-communicable diseases in 2025. The results will be shared through academic conferences and journals and communicated to the schools and the communities.

1 July 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
EDEric Arnaud Diendéré
Eric Arnaud Diendéré
KSKongnimissom Apoline Sondo
Kongnimissom Apoline Sondo
AOAbdoul Risgou OUEDRAOGO
Abdoul Risgou OUEDRAOGO
DDDésiré Lucien Dahourou
Désiré Lucien Dahourou
KCKadari Cissé
Kadari Cissé
SKSeni Kouanda
Seni Kouanda
COVID-19 is one of the world’s major health crises. The objective of this study was to determine the predictive factors of severe hypoxemia in patients hospitalized in COVID-19 health facilities in Burkina Faso. This study was a hospital-based cross-sectional study. The data collected relate to the period of the first wave of the epidemic (March 9 to June 30, 2020). All patients hospitalized for COVID-19 in the requisitioned health facilities of Ouagadougou were included in this study. Predictors of severe hypoxemia were identified using a multivariate logistic regression model. During the study period, 442 patients were included, representing 45.7% of the total number of positive patients in the entire country. The most common co-morbidities were diabetes (55; 12.4%) and arterial hypertension (97; 21.9%). Severe hypoxemia (SpO2 < 90%) was observed in 64 patients (14.5%). Age over 65 years (OR = 8.24; 95% CI: 2.83–24.01) and diabetes (OR = 2.43; 95% CI: 1.17–5.06) were the predictors for occurrence of severe hypoxemia in multivariate analysis. The predictive factors of COVID-19 are similar in African and Caucasian populations. The surveillance of COVID-19 in risk groups should be strengthened to reduce their morbidity and mortality.

1 August 2015 in Revue de Pneumologie Clinique
Verified
Journal Article
Closed access
EBE.L.P. Bemba
E.L.P. Bemba
KHK. Horo
K. Horo
FOF.H. Okemba Okombi
F.H. Okemba Okombi
KAK.B. Ossale Abacka
K.B. Ossale Abacka
AOAbdoul Risgou OUEDRAOGO
Abdoul Risgou OUEDRAOGO
EDE. Aka Danguy
E. Aka Danguy

1 February 2018 in Revue de Pneumologie Clinique
Verified
Journal Article
Closed access
EBE.L.P. Bemba
E.L.P. Bemba
AOAbdoul Risgou OUEDRAOGO
Abdoul Risgou OUEDRAOGO
GNG.C. Ngouoni
G.C. Ngouoni
RBR.G. Bopaka
R.G. Bopaka
PKP.P. Koumeka
P.P. Koumeka
JMJ. Mboussa
J. Mboussa